FDX vs GLUE · P/E 18, rev $94.72B vs rev $13.2M
FedEx Corporation (FDX) versus Monte Rosa Therapeutics Inc (GLUE) — a side-by-side from cached financials, not a winner call.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
FDX currently screens at market cap $78.98B and trailing P/E 17.7. GLUE currently screens at market cap $1.56B.
Not investment advice. Open the FDX and GLUE stock pages for the full models.
Not investment advice.